Keywords: sopherion, raises, 47m, buys, myocet, rights, usa-based

Sopherion raises $47M; buys Myocet rights

Article | 04 October 2004

Print This

USA-based biotechnology firm Sopherion Therapeutics has completed a $47 million Series B venture funding, in a round led TL Ventures.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in